Nordic products are globally recognized as premium products – qualitative, and reliable.
And the Chinese market offers ample business opportunities.
We invite You to be part of an interactive webinar, where Nordic entrepreneurs and experts from scientific fields will be looking forward to 2021 – how we see export to China taking shape.
Date and Time: January 20th, 10 am (EET / GMT +2)
REGISTRATION: https://forms.gle/oHGYRADWNeHj8R8k6
Working language: English
AGENDA, SPEAKERS & PRESENTATIONS
10:00 – 10:05 How NovelBaltic project can connect you with relevant contacts in China | Hely Häggman, University of Oulu
10:05 – 10:20 Future priorities of BSR Programme in supporting companies | Lukasz Korpal, BSR Programme Finance Unit
10:20 – 10:55 Establishing a Nordic business in China, case of BMH Technology Oy | Leena Faven, Centria
10:55 – 11:20 Cooperation case between University of Latvia and System Innovations Ltd | Linards Klavins, University of Latvia & Kristaps English, System Innovations Ltd
11:20 – 11:45 DNA-barcoding technology in authenticity analysis of products in China | Dr. Zhang Bolin, Beijing Forestry University
11:45 – 11:55 Sneak peek into Market Intelligence Report on China | Tartu Science Park & Ilona Vanaga, Silv EXPO Ltd
11:55 – 12:00 Final Questions and goodbyes
Additional information: Vaido Mikheim, vaido@sciencepark.ee, +372 53095906
Registration is mandatory: https://forms.gle/oHGYRADWNeHj8R8k6
The event link will be sent to all registered participants on the 18th of January
The webinar is brought to you by Tartu Science Park and partners in the framework of the NovelBaltic project. It is part-funded by the European Regional Development Fund via Interreg Baltic Sea Region.
More detailed information and link to event registration can be found here:
Facebook event https://www.facebook.com/events/3105911182806291/
Tartu Science Park website https://teaduspark.ee/en/exporting-nordic-natural-products-to-asian-markets/
Exporting_Nordic_natural_products_to_Asian_markets_Agenda.pdf
NovelBaltic_SilvEXPO_10-06-20_Asia_experience.pdf
ABOUT THE PROJECT
The project aims to explore the wild and cultivated forest and bog berry (genus Vaccinium) extractives' composition, using environmentally friendly, solvent-free extraction methods for the isolation of biologically active substances, as well as an in-depth pharmacological activity studies in vitro in order to obtain substances for biopharmaceutical and biomedical applications and to develop innovative health products. During the project it is expected to prepare several original scientific papers, submitted for publishing in journals or conference proceeding included in Web of Science or SCOPUS databases, to develop a product protected by patent and the method of its extraction, as well as elaborate a the prototype of innovative health product and recommendations for its use.
More information about the project and its progress you can find here: https://www.lu.lv/berriespro/
In the "Innovation" magazine you can read an article about our project and how we plan to use the power of berries growing in Latvian forests and swamps — and do it to the very last drop, turning pomace left over from food processing into nutritional supplements.
The article: Pages_from_innovation_2_EGN_NEW_26.02_small.pdf
You can view the magazine here: https://www.rtu.lv/en/university/for-mass-media/magazine-innovation
Beneficiary: University of Latvia and SIA "Silv EXPO"
Co-operation Authority: CFLA
The study was carried out on the grounds and within the framework of contract No. L-KAP-12-0005 on the realisation of the project “The Promotion of Cooperation Between the Members of Pharmaceutical and Related Field Cluster to Increase Productivity and Export Capacity of the Field Using the Methods of Combined Strategic Planning, Cooperative Logistics and Marketing, and Specialised Research Technological Infrastructure” concluded between The Association of Latvian Chemical and Pharmaceutical Industry and the government agency “The Investment and Development Agency of Latvia”.
The aim of the study – to develop an original medical device (lozenge) using innovative raw materials (including those produced in Latvia) and the most recent technological solutions – adding mucoadhesive polymers and humectants to the base of the lozenge.
During the course of the study a pilot series was developed for an anti-cold lozenge that contains the raw material silbiol extracted from pine and spruce tree needles. The use of raw materials produced in Latvia will promote local production and ensure long-term competitiveness in EU export markets as the unique production technology of raw materials, usage of Latvian natural resources and planned patenting of the new product will protect the product against the arrival of new similar products and copies.
The study was carried out on the grounds and within the framework of contract No. L-KC-11-0005 on the realisation of the project “Environment, Bioenergy and Biotechnology Competence centre” concluded on 11. 04. 2011 between LLC “Environment, Bioenergetics and Biotechnology Competence centre” and the government agency “The Investment and Development Agency of Latvia”.
During the course of the study plant polyprenols were examined, that are the source of endogenous dolichol and dolichol phosphate biosynthesis within an organism, the seasonal changes of content in Latvian Norway spruce (Picea abies (L.) Karst.) needle foliage, as well as an optimisation plan was developed for polyprenol extraction technology. The study did not involve the examination of needle isoprene alcohol biological activity, as this study was concluded in the first activity and the second was not commenced.
The study was carried out on the grounds and within the framework of contract No. L-KC-11-0001 on the realisation of the project “Pharma and Chemistry Competence Centre of Latvia” concluded on 5 April, 2011 between LLC “Pharma and Chemistry Competence Centre of Latvia” and the government agency “The Investment and Development Agency of Latvia”.
The aim of the study – to find an innovative way to reduce or prevent statin-induced side effects through the usage of plant polyprenols by studying the role of plant polyprenols in statin-induced myopathy reduction on in vivo models, as well as polyprenol effects on the models of multiple sclerosis and cognition study of rats.
There were separate studies on:
The results of the study would provide new knowledge for the further development of this field of research, so that it would be possible in the future to find an innovative way to reduce or prevent statin side effects and create a scientifically proven medical effect spectre of polyprenols.
The study was carried out on the grounds and within the framework of contract No. L-KC-11-0001 on the realisation of the project “Pharma and Chemistry Competence Centre of Latvia” concluded on 5 April, 2011 between LLC “Pharma and Chemistry Competence Centre of Latvia” and the government agency “The Investment and Development Agency of Latvia”.
The aim of the study was to assess the influence of Baltic origin plant and berry bioactive substances on the reduction or prevention of metal-containing chemotherapy drugs’ induced adverse reactions by identifying the biological activity of different natural extracts in in vitro and in vivo models.
For the study 4 plant extracts were used: polyprenols from coniferous trees, carotenoid paste, sea buckthorn sprout extract, sodium chlorophyllin extract.
There were separate studies on:
The new knowledge will be used to develop formulations of a potential new natural substance preparation that in the long term could become a foundation to create and introduce new innovative hepatoprotectors (food supplements) for the benefit of chemotherapy patients.